A new drug, asciminib, has shown promising results as a safer and more effective treatment for patients with newly diagnosed CML.
Scientists continue to look for new drugs to treat CML, especially CML that no longer responds to TKIs. In some people, CML cells develop a change in the BCR-ABL oncogene known as a T315I mutation, which makes them resistant to many of the TKI drugs used today.
Drug Administration for the treatment of chronic myelogenous leukemia (CML). Clinical trials of new drugs start in the sickest patientsthose
The new approval not only approximately doubles the drug's eligible treatment Conquering CML: The Breakthrough Paradigm Change of Treatment-
Accelerated phase CML is more difficult to control with medications, probably because of new mutations that develop in the CML cells. ○Blast
Professor Helgason is researching a new way to treat CML by combining drug treatments with other treatment methods.
New Drugs for CML; Update on the French and German Interferon combination studies; Age-adjusted treatment in CML- Elderly and Pregnancy report for young CML
A new drug, asciminib, has shown promising results as a safer and more effective treatment for patients with newly diagnosed CML.
CML Gold Standard SOHO 2024 For Treatment Value, Imatinib Remains the CML Gold Standard New Trials ESC 2024 Time Antihypertensives Taken Doesn't Matter: New
Comments